[en] The proportion of counterfeit medicines is dramatically increasing these last few years. According to numerous official sources, in some pharmaceutical wholesalers in African countries, the proportion has reached 80%. Unfortunately, this situation is far to be improved due to lack of suitable analytical equipment allowing rapid actions of the Regulatory Agencies based on scientific consideration, at affordable cost and all over the drug supply chain. For that purpose, a network group considered that mater by building a low-cost original capillary electrophoresis (CE) equipment equipped with a new deep UV detector based on LED technology. The generic conditions for analysis were investigated: capillary zone electrophoresis (CZE) performed at acidic pH for basic drug molecules (i.e., quinine, highly used as the last antimalarial rampart), basic pH for compounds such as furosemide (a common diuretic drug) and at neutral pH for a well known antibiotic combination, trimethoprim/sulfamethoxazol. To evaluate the ability of the CE equipment for quantification, a full validation and a method comparison study were carried out for the CZE method dedicated to quinine determination. The validation involved the use of accuracy profile and total error concept to monitor the adequacy of the results obtained by the new prototype. The method comparison was based on the Bland and Altman approach by comparing results obtained by the low-cost CE and a conventional set-up. Subsequent validation studies were realized with neutral and acidic drug molecules, each focusing on a single concentration level calibration curve in order to maintain as low as possible the expenses due to reagents and thus the cost of analysis, as important advantages of CE for drug quality control.
F.R.S.-FNRS - Fund for Scientific Research CUD - Commission Universitaire pour le Développement Walloon region University of Applied Sciences and Arts Western Switzerland
Funding text :
A research grant from the Belgium National Fund for Scientific Research (FRS-FNRS) to E. Rozet is gratefully acknowledged as well as the research grant from the Belgian Coopération Universitaire au Développement (CUD, R.D. Marini) and Walloon Project PPP (Convention OPTIMAL DS No. 917007, R.D. Marini). Research grant from University of applied sciences of western Switzerland (Fribourg) Projet d’institut iTIN, Sagex No. 11480/19870 were received for the low-cost CE device development (C. Rohrbasser, D. Rhème, J.-L. Veuthey, S. Rudaz).
Cockburn, R., Newton, P.N., Agyarko, E.K., Akunyili, D., White, N.J., Correction: the global threat of counterfeit drugs: why industry and governments must communicate the dangers (2005) PLoS Med., pp. e100
Westenberger, B.J., Ellison, C.D., Fussner, A.S., Jenney, S., Kolinski, R.E., Lipe, T.G., Lyon, R.C., Buhse, L.F., Quality assessment of Internet pharmaceutical products using traditional and non-traditional analytical techniques (2005) Int. J. Pharm., 306, pp. 56-70
(2007), http://ec.europa.eu/taxation_customs/customs/customs_controls/counterfeit_piracy/combating/index_en.htm, European Commission, Combating counterfeit & piracy, (July 2010)
Delavaux, J., (2009) En Marche, Bimensuel 1410, p. 6. , Le Congo malade de faux médicaments
Burns, W., (2006) Bull. World Health Org., 84, pp. 689-690
(2007) IMPACT General Meeting, pp. 1-13. , International Medical Products Anti-Counterfeiting Taskforce, Principles and Elements for National Legislation Against Counterfeit Medical Products
(2009) New FDA Initiative to Combat Counterfeit Drugs, , http://www.fda.gov/oc/initiatives/counterfeit/backgrounder.html, U.S. Food and Drug Administration, (July 2010), 28 F
Trefi, S., Routaboul, C., Hamieh, S., Gilard, V., Malet-Martino, M., Martino, R., Analysis of illegally manufactured formulations of tadalafil (Cialis®) by 1H NMR, 2D DOSY 1H NMR and Raman spectroscopy (2008) J. Pharm. Biomed. Anal., 47, pp. 103-113
de Veij, M., Deneckere, A., Vandenabeele, P., de Kaste, D., Moens, L., Detection of counterfeit Viagra® with Raman spectroscopy (2008) J. Pharm. Biomed. Anal., 46, pp. 303-309
Green, M.D., Nettey, H., Villalva Rojas, O., Pamanivong, C., Khounsaknalath, L., Grande Ortiz, M., Newton, P.N., Manolin, O., Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality (2007) J. Pharm. Biomed. Anal., 43, pp. 105-110
Maurin, J.K., Plucínski, F., Mazurek, A.P., Fijałek, Z., The usefulness of simple X-ray powder diffraction analysis for counterfeit control-the Viagra® example (2007) J. Pharm. Biomed. Anal., 43, pp. 1514-1518
de Peinder, P., Vredenbregt, M.J., Visser, T., de Kaste, D., Detection of Lipitor® counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics (2008) J. Pharm. Biomed. Anal., 47, pp. 688-694
Rodionova, O., Houmøller, L.P., Pomerantsev, A.L., Geladi, P., Burger, J., Dorofeyev, V.L., Arzamastsev, A.P., NIR spectrometry for counterfeit drug detection. A feasibility study (2005) Anal. Chim. Acta, 549, pp. 151-158
Westenberger, B.J., Ellison, C.D., Fussner, A.S., Jenney, S., Kolinski, R.E., Lipe, T.G., Lyon, R.C., Buhse, L.F., Quality assessment of Internet pharmaceutical products using traditional and non-traditional analytical techniques (2005) Int. J. Pharm., 306, pp. 56-70
Puchert, T., Lochmann, D., Menezes, J.C., Reicha, G., Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification. A four stage concept with a novel approach of data processing (Linear Image Signature) (2010) J. Pharm. Biomed. Anal., 51, pp. 138-145
Storme-Paris, I., Rebiere, H., Matoga, M., Civade, C., Bonnet, P.-A., Tissier, M.H., Chaminade, P., Challenging near infrared spectroscopy discriminating ability for counterfeit pharmaceuticals detection (2010) Anal. Chim. Acta, 658, pp. 163-174
Rebiere, H., Mazel, B., Civade, C., Bonnet, P.-A., Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography (2007) J. Chromatogr. B, 850, pp. 376-383
Schad, G.J., Allanson, A., Mackay, S.P., Cannavan, A., Tettey, J.N.A., Development and validation of an improved HPLC method for the control of potentially counterfeit isometamidium products (2008) J. Pharm. Biomed. Anal., 46, pp. 45-51
Panusa, A., Multari, G., Incarnato, G., Gagliardi, L., High-performance liquid chromatography analysis of anti-inflammatory pharmaceuticals with ultraviolet and electrospray-mass spectrometry detection in suspected counterfeit homeopathic medicinal products (2007) J. Pharm. Biomed. Anal., 3, pp. 1221-1227
Wynia, G.S., Windhorst, G., Post, P.C., Maris, F.A., Development and validation of a capillary electrophoresis method within a pharmaceutical quality control environment and comparison with high-performance liquid chromatography (1997) J. Chromatogr. A, 773, pp. 339-350
Mayer, B.X., Müller, M., Long-term analyses with capillary electrophoresis (2001) LC-GC Europe, pp. 2-7
Altria, K.D., Hadgett, T.A., An evaluation of the use of capillary electrophoresis to monitor trace drug residues following the manufacture of pharmaceuticals (1995) Chromatographia, 40, pp. 23-27
Marini, R.D., Matthijs, N., Vander Heyden, Y., Smeyers-Verbeke, J., Dehouck, P., Hoogmartens, J., Silvestre, P., Hubert, P., Collaborative study on a liquid chromatographic method for the determination of R-timolol and other related substances in S-timolol maleate (2005) Anal. Chim. Acta, 546, pp. 182-192
Marini, R.D., Groom, C., Doucet, F.R., Hawari, J., Bitar, Y., Holzgrabe, U., Gotti, R., Hubert, P., Interlaboratory study of a NACE method for the determination of R-timolol content in S-timolol maleate: assessment of uncertainty (2006) Electrophoresis, 27, pp. 2386-2399
Harvey, D., (2004) Quimica Analitica Moderna, , McGraw-Hill, Madrid, Spain
Altria, K.D., Rudd, D.R., An overview of method validation and system suitability aspects in capillary electrophoresis (1995) Chromatographia, 41, pp. 325-331
Hubert, P., Nguyen-Huu, J.J., Boulanger, B., Chapuzet, E., Chiap, P., Cohen, N., Compagnon, P.A., Valat, L., Validation des procédures analytiques quantitatives, Harmonisation des démarches, S.T.P. (2003) Pharma Pratiques, 13, pp. 101-138
Hubert, P., Nguyen-Huu, J.-J., Boulanger, B., Chapuzet, E., Chiap, P., Cohen, N., Compagnon, P.-A., Valat, L., Harmonization of strategies for the validation of quantitative analytical procedures. A SFTP Proposal-Part 1 (2004) J. Pharm. Biomed. Anal., 36, pp. 579-586
http://www.psi-inc.org/index.cfm, Pharmaceutical Security Institute, The Counterfeit Medicines Challenge,
Rohrbasser, C., Rhême, D., Décastel, S., Roth, S., de Lourdes Aja Montes, M., Veuthey, J.-L., Rudaz, S., A new capillary electrophoresis device with deep UV detector based on LED technology (2009) Chimia, 63, pp. 890-891
Rohrbasser, C., Rhême, D., Décastel, S., Roth, S., Veuthey, J.-L., Rudaz, S., (2008), A new deep UV detector for capillary electrophoresis based on LED technology, Unpublished report
Altria, K.D., Long term analysis with capillary electrophoresis (2002) LC-GC Europe, 1, pp. 1-5
Liu, H.-Y., Ding, W.-H., Determination of homologues of quaternary ammonium surfactants by capillary electrophoresis using indirect UV detection (2004) J. Chromatogr. A, 1025, pp. 303-312
Marini, R.D., Servais, A.-C., Rozet, E., Chiap, P., Boulanger, B., Rudaz, S., Crommen, J., Fillet, M., Nonaqueous capillary electrophoresis method for the enantiomeric purity determination of S-timolol using heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin: validation using the accuracy profile strategy and estimation of uncertainty (2006) J. Chromatogr. A, 1120, pp. 102-111
Marini, R.D., Chiap, P., Boulanger, B., Rudaz, S., Rozet, E., Crommen, J., Hubert, P., LC method for the determination of R-timolol in S-timolol maleate: validation of its ability to quantify and uncertainty assessment (2006) Talanta, 68, pp. 1166-1175
Mee, R., β-expectation and β-content tolerance limits for balanced one-way ANOVA random model (1984) Technometrics, 26, pp. 251-253
Feinberg, M., Boulanger, B., Dewé, W., Hubert, P., New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data (2004) Anal. Bioanal. Chem., 380, pp. 502-514
Bouabidi, A., Rozet, E., Fillet, M., Ziemons, E., Chapuzet, E., Mertens, B., Klinkenberg, R., Hubert, P., Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept (2010) J. Chromatogr. A, 1217, pp. 3180-3192
(2005) International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva
Bland, J.M., Altman, D.G., Statistical methods for assessing agreement between two methods of clinical measurement (1986) Lancet, pp. 307-310
Dewé, W., Govaerts, B., Boulanger, B., Rozet, E., Chiap, P., Hubert, P., Using total error as decision criterion in analytical method transfer (2007) Chemometr. Intell. Lab. Syst., 85, pp. 262-268
